29 min listen
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
ratings:
Length:
65 minutes
Released:
Jan 31, 2024
Format:
Podcast episode
Description
Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer.
CME information and select publications here (https://www.researchtopractice.com/YiR2023/HRPosBC).
CME information and select publications here (https://www.researchtopractice.com/YiR2023/HRPosBC).
Released:
Jan 31, 2024
Format:
Podcast episode
Titles in the series (100)
Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber: Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations. by Oncology Today with Dr Neil Love